[HTML][HTML] Interleukin-6 and type-I collagen production by systemic sclerosis fibroblasts are differentially regulated by interleukin-17A in the presence of transforming …

AM Dufour, M Alvarez, B Russo… - Frontiers in …, 2018 - frontiersin.org
… jointly to fibroblasts. To address this issue, we used the fibroblast production of IL-6, MCP-1, …
17A and TGF-β induced synergic responses specifically for IL-6 and MCP-1, but not for IL-8 (…

Interleukin6: a new therapeutic target in systemic sclerosis?

S O'reilly, R Cant, M Ciechomska… - Clinical & …, 2013 - Wiley Online Library
… it has been shown that epidermis stains very strongly for IL-6 and also fibroblasts in the …
to IL-6 in fibroblasts. In vitro cultures of dermal fibroblast cultured with anti-IL-6 antibodies …

Scleroderma peripheral B lymphocytes secrete interleukin6 and transforming growth factor β and activate fibroblasts

N Dumoitier, B Chaigne, A Régent… - Arthritis & …, 2017 - Wiley Online Library
… macrophages in systemic sclerosis with lung involvement. Am J … sclerosis produce
increased amounts of interleukin 6, but not transforming growth factor b 1. J Rheumatol 1996;23:291–6

Clinical and pathological significance of interleukin 6 overexpression in systemic sclerosis

K Khan, S Xu, S Nihtyanova, E Derrett-Smith… - Annals of the …, 2012 - ard.bmj.com
… systemic sclerosis (SSc) skin fibroblasts and the effect of IL-6 trans-signalling on fibroblasts.
… mRNA measurement of IL-6 in cultured SSc and normal fibroblasts. Data are representative …

The many faces of interleukin6: the role of IL‐6 in inflammation, vasculopathy, and fibrosis in systemic sclerosis

TC Barnes, ME Anderson… - International journal of …, 2011 - Wiley Online Library
Fibroblasts from patients with SSc are phenotypically unique. … IL-6 is a profibrogenic cytokine.
It has been shown to either increase or decrease fibroblast proliferation, increase fibroblast

… interleukin-6 blockade reverses transforming growth factor-beta pathway activation in dermal fibroblasts: insights from the faSScinate clinical trial in systemic sclerosis

CP Denton, VH Ong, S Xu, H Chen-Harris… - Annals of the …, 2018 - ard.bmj.com
… dermal fibroblasts is a hallmark of systemic sclerosis (SSc), … factor-beta (TGFβ) and interleukin-6
(IL-6) are key candidate … IL-6 pathway blockade on the biology of SSc fibroblasts in vivo …

… production of interleukin-6 (IL-6), oncostatin M and soluble IL-6 receptor by cultured peripheral blood mononuclear cells from patients with systemic sclerosis.

M Hasegawa, S Sato, H Ihn… - Rheumatology (Oxford …, 1999 - academic.oup.com
… collagen clinical aspects of interleukin 6. Immunol Today by normal fibroblasts appear to
be … dermal fibroblasts by recombinant human interleukin 6. J Invest Dermatol 1991;97:686–92. …

Control of IL-6 expression and response in fibroblasts from patients with systemic sclerosis

CA Feghali, KL Bost, DW Boulware, LS Levy - Autoimmunity, 1994 - Taylor & Francis
… Stimulation of collagen and glycosaminoglycan production in cultured human adult dermal
fibroblasts by recombinant human interleukin 6. J Invest Dermatol 199 1: 97: 686-692. LeRoy …

[HTML][HTML] Endogenous IL-1α from systemic sclerosis fibroblasts induces IL-6 and PDGF-A

Y Kawaguchi, M Hara, TM Wright - The Journal of clinical …, 1999 - Am Soc Clin Investig
… reported that fibroblasts derived from clinically affected skin areas of patients with systemic
sclerosis (SSc) have the ability to overproduce several cytokines and growth factors (ie, IL-6, …

Systemic sclerosis fibroblasts show specific alterations of interferon-γ and tumor necrosis factor-α-induced modulation of interleukin 6 and chemokine ligand 2

A Antonelli, P Fallahi, SM Ferrari, D Giuggioli… - The Journal of …, 2012 - jrheum.org
… Enhanced interleukin 6 production by cultured fibroblasts from patients with systemic
sclerosis in response to platelet derived growth factor. J Rheumatol 1998;25:1534–9. …